• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Stigmastanes and derivatives
• Euonymus japonicus Thunb.
• Natural Products and Extracts Plant Extracts Plant based Unonopsis guatterioides
• Natural Products and Extracts Plant Extracts Plant based Thomandersia laurifolia
• Natural Products and Extracts Plant Extracts Plant based Siler montanum
• Natural Products and Extracts Plant Extracts Plant based Sapranthus palanga
• Natural Products and Extracts Plant Extracts Plant based Retanilla trinervia
• Natural Products and Extracts Plant Extracts Plant based Poraqueiba guianensis
• Natural Products and Extracts Plant Extracts Plant based Platypodium elegans
• Natural Products and Extracts Plant Extracts Plant based Nealchornea yapurensis
• Natural Products and Extracts Plant Extracts Plant based Malleastrum boivinianum
• Natural Products and Extracts Plant Extracts Plant based Lysiloma acapulcense
• Natural Products and Extracts Plant Extracts Plant based Laser trilobum
• Natural Products and Extracts Plant Extracts Plant based Esenbeckia pentaphylla
• Natural Products and Extracts Plant Extracts Plant based Esenbeckia berlandieri
• Natural Products and Extracts Plant Extracts Plant based Erucaria microcarpa
• Natural Products and Extracts Plant Extracts Plant based Eriolarynx australis
• Natural Products and Extracts Plant Extracts Plant based Diphysa americana
• Natural Products and Extracts Plant Extracts Plant based Condea albida

Comprehensive Analysis of Stigmast-5-en-3-ol (CAS No. 5779-62-4): Properties, Applications, and Industry Trends

Stigmast-5-en-3-ol, identified by its CAS number 5779-62-4, is a naturally occurring sterol compound belonging to the class of phytosterols. This bioactive molecule has garnered significant attention in recent years due to its potential health benefits and applications in nutraceuticals, cosmetics, and pharmaceuticals. The compound is structurally characterized by a stigmastane skeleton with a double bond at the 5-position and a hydroxyl group at the 3-position, which contributes to its unique physicochemical properties.

In the context of rising consumer demand for plant-derived bioactive compounds, Stigmast-5-en-3-ol has emerged as a subject of interest for researchers exploring natural cholesterol-lowering agents and anti-inflammatory compounds. Recent studies published in journals like Phytochemistry and Journal of Agricultural and Food Chemistry highlight its potential to modulate lipid metabolism, making it relevant to current discussions about functional foods and cardiovascular health.

The extraction and purification of CAS 5779-62-4 typically involve advanced techniques such as supercritical fluid extraction (SFE) and preparative HPLC, reflecting the growing sophistication of phytochemical isolation methods. Analytical characterization often employs NMR spectroscopy and mass spectrometry, with the compound typically appearing as a white crystalline powder with a melting point range of 140-145°C. These technical specifications are particularly relevant for quality control in industrial applications.

From a commercial perspective, the global market for phytosterols like Stigmast-5-en-3-ol is projected to grow at a CAGR of 8.5% from 2023 to 2030, according to Grand View Research. This growth is driven by increasing awareness of plant-based therapeutics and the compound's potential role in skin barrier enhancement – a hot topic in cosmetic science. Formulators are particularly interested in its ability to interact with ceramide pathways, which aligns with current trends in anti-aging skincare.

In pharmaceutical research, derivatives of 5779-62-4 are being investigated for their potential as selective estrogen receptor modulators (SERMs), with preliminary studies suggesting structure-activity relationships worth exploring. This connects to broader discussions about natural alternatives to hormone therapy, a frequently searched topic in medical forums and academic databases.

The stability profile of Stigmast-5-en-3-ol makes it suitable for various delivery systems, including nanoparticle encapsulation and liposomal formulations – technologies that dominate current patent filings in the nutraceutical sector. Its logP value of approximately 8.5 indicates high lipophilicity, an important consideration for bioavailability enhancement strategies that are central to modern drug delivery research.

Environmental considerations are also shaping the narrative around CAS 5779-62-4. As a compound derived from plant sources like soybean oil or tall oil, its production aligns with the green chemistry movement and sustainable sourcing initiatives. Life cycle assessments of phytosterol production are becoming increasingly important to manufacturers responding to consumer demand for eco-friendly ingredients.

From a regulatory standpoint, Stigmast-5-en-3-ol is generally recognized as safe (GRAS) when used in accordance with good manufacturing practices. However, the evolving landscape of nutraceutical regulations and health claim substantiation requirements continues to influence its commercial applications. This regulatory dimension is particularly relevant to product developers navigating the complex dietary supplement market.

Recent advances in biocatalysis have opened new possibilities for the structural modification of 5779-62-4, with enzyme-mediated transformations offering routes to novel derivatives with enhanced bioactivity. These developments connect to broader trends in white biotechnology and the search for sustainable methods of molecular diversification.

In analytical chemistry, the detection and quantification of Stigmast-5-en-3-ol in complex matrices has benefited from advances in UHPLC-MS/MS techniques. These methodological improvements are crucial for quality assurance in products containing this compound, especially given the current emphasis on supplement authentication and adulteration prevention in the industry.

The scientific literature reveals growing interest in the potential synergistic effects between CAS 5779-62-4 and other phytochemicals, particularly in the context of entourage effects in botanical extracts. This area of research taps into popular discussions about whole-plant medicine and the limitations of single-compound approaches to phytotherapy.

Looking forward, the applications of Stigmast-5-en-3-ol are likely to expand as research uncovers new biological activities. Current investigations into its effects on gut microbiota and bile acid metabolism suggest potential applications in microbiome modulation – one of the most rapidly growing areas in nutritional science today.

• 559-70-6(β-Amyrin)
• 432-60-0(Allylestrenol)
• 83-48-7(Stigmasterol)
• 1963-03-7(Androst-5-ene-3,17-diol,(3b,17a)-)
• 521-10-8(Methandriol)
• 521-17-5(Androstenediol)
• 545-46-0(Uvaol)
• 545-48-2(3b-Erythrodiol)
• 83-46-5(beta-Sitosterol)
• 150044-24-9(Cholesterol-13C5)